Switch to:
More From Other Websites
Inside Vertex’s Revenue Expectations for 2017 Feb 24 2017
Vertex Expects Modest Revenue Growth in This Feb 24 2017
Understanding Vertex’s Analyst Recommendations Feb 24 2017
Headcount at ​Vertex surges in 2016, hitting four-year high Feb 23 2017
VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-K, Annual Report Feb 23 2017
Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and... Feb 13 2017
5 Toxic Stocks to Dump or Play Short for Gains Feb 09 2017
Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen Jan 27 2017
Biotech M&A Activity Expected to Rise in 2017: Latest Reports on Exelixis and Vertex Pharmaceuticals Jan 27 2017
Blog Coverage Celgene Acquires Delinia; Set to Expand Inflammation and Immunology Portfolio Jan 27 2017
Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017 Jan 26 2017
Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up Jan 26 2017
Edited Transcript of VRTX earnings conference call or presentation 25-Jan-17 9:30pm GMT Jan 25 2017
Vertex tops Street 4Q forecasts Jan 25 2017
Vertex tops Street 4Q forecasts Jan 25 2017
[$$] Vertex Pharmaceuticals Swings to Profit Jan 25 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK